Patent details

Basic Information

Publication number:

EP1626709

PCT Application Number:

PCT/US/2004/003821

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047098702

PCT Publication Number:

WO/2004/071501

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ENANTIOMERIC AMPHETAMINE COMPOSITIONS FOR THE TREATMENT OF ADHD

French Title of Invention:

COMPOSITIONS ENANTIOMERIQUES D'AMPHETAMINE POUR TRAITER L'ADHD

German Title of Invention:

ENANTIOMERE AMPHETAMINE ENTHALTENDE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON AUFMERKSAMKEITSDEFIZIT-/HYPERAKTIVITÄTSSTÖRUNG (ADHD)

SPC Number:

Dates

Filing date:

10/02/2004

Grant date:

05/09/2007

EP Publication Date:

05/09/2007

PCT Publication Date:

26/08/2004

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/02/2006

EP B1 Publication Date:

05/09/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

10/02/2008

Expiration date:

10/02/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/03/2008

 

 

Name:

Shire Canada Inc.

Address:

2250 Alfred-Nobel Boulevard, Suite 500, Ville St-Laurent, QC H4S 2C9, Canada (CA)

Inventor

1

Name:

COUCH Richard, A.

Address:

United States (US)

2

Name:

MICHAELS A. Shire Pharmaceutical Development Inc.

Address:

United States (US)

3

Name:

HODGKINS Paul

Address:

United States (US)

Priority

1

Priority Number:

445793 P

Priority Date:

10/02/2003

Priority Country:

United States (US)

2

Priority Number:

473925 P

Priority Date:

29/05/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/137;

Filing date	Document type	Number of pages